부산대학교 도서관

Veskimäe, K ; Scaravilli, M ; Niininen, W ; Karvonen, H ; Jaatinen, S ; Nykter, M ; Visakorpi, T ; Mäenpää, J ; Ungureanu, D ; Staff, S

In Translational Oncology October 2018 11(5):1160-1170

Uusi-Makela, M; Harjula, S-KE; Junno, M; Sillanpaa, A; Natkin, R; Niskanen, MT; Saralahti, AK; Nykter, M; Ramet, M

DISEASE MODELS & MECHANISMS. 18(9)

Tiihonen, A M; Salonen, I; Koivisto, I; Ritamäki, A S; Jaatinen, S; Hyvärinen, T; Lotila, J; Kreutzer, J; Valkonen, M; Karabiyik, G; Mäntylä, S; Mohammadlou, M; Hoikka, M; Beck, J; Rölz, R; Marttinen, M; Nykter, M; Haapasalo, J; Ruusuvuori, P; Parkkila, S; Kallio, P; Hagman, S; Kesseli, J; Ravi, V; Haapasalo, H; Jukkola, A; Joseph, K; Rautajoki, K J

Neuro Oncol

Virtanen T; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Eastern Health Clinical School, Monash University, Melbourne, Australia.; Parekh K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Huang CF; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Yu IPL; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Ryyppö L; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Bernales CQ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Tam C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Sipola J; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Nikkola J; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Kukkonen K; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Adelia; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Eigl BJ; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Finch D; BC Cancer - Cancer Centre for the Southern Interior, Kelowna, Canada.; Gagnon R; Tom Baker Cancer Centre, Calgary, Canada.; Takieldeen Y; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indiana, USA.; Hardy E; BC Cancer - Vernon Cancer Centre, Vernon, Canada.; Khalaf D; Sunnybrook Health Sciences Centre, Toronto, Canada.; Kollmannsberger C; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Lavoie JM; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Maurice-Dror C; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Miller S; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Nappi L; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Noonan K; BC Cancer - Surrey Cancer Centre, Surrey, Canada.; Parimi S; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Riminchan A; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Sartori-Mueller E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Soleimani M; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Vergidis J; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Zulfiqar M; BC Cancer - Abbotsford Cancer Centre, Abbotsford, Canada.; Hansen A; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Hotte S; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Canada.; Jafri M; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.; Kolinsky M; Cross Cancer Institute, Edmonton, Canada.; Mukherjee SD; Department of Oncology, McMaster University, Hamilton, Canada.; Ong M; Ottawa Hospital Research Institute, Ottawa, Canada.; Rose AAN; Segal Cancer Center, Jewish General Hospital & McGill University, Montreal, Canada.; Tu W; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Winquist E; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Canada.; Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Canada.; van der Zande K; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Canada.; Zwart W; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Canada; Oncode Institute, Utrecht, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van Erp NP; Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.; Zhao JL; Department of SystImmune Inc, Redmond, USA.; Rathkopf D; Department of Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Weill Cornell Medical College, New York, USA.; Barbieri CE; Department of Urology, Weill Cornell Medicine, New York, USA.; Quigley DA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, USA.; Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Lack NA; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Medical Pharmacology, School of Medicine, Koç University, Istanbul, Turkey.; Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland. Electronic address: matti.annala@tuni.fi.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, Canada. Electronic address: alexander.wyatt@ubc.ca.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Karvonen, H; Chiron, D; Niininen, W; Ek, S; Jerkeman, M; Moradi, E; Nykter, M; Heckman, CA; Kallioniemi, O; Murumagi, A

BLOOD ADVANCES. 1(24):2257-2268

Filppu, P; Ramanathan, JT; Granberg, KJ; Gucciardo, E; Haapasalo, H; Lehti, K; Nykter, M; Le, Joncour V; Laakkonen, P

JCI INSIGHT. 6(9)

Salenius, K; Valja, N; Thusberg, S; Iris, F; Ladd-Acosta, C; Roos, C; Nykter, M; Fasano, A; Autio, R; Lin, J

BMC PSYCHIATRY. 24(1)

Salenius, K; Väljä, N; Thusberg, S; Iris, F; Ladd-Acosta, C; Roos, C; Nykter, M; Fasano, A; Autio, R; Lin, J

medRxiv.

Li, X; Liu, Y; Granberg, K J; Wang, Q; Moore, L M; Ji, P; Gumin, J; Sulman, E P; Calin, G A; Haapasalo, H; Nykter, M; Shmulevich, I; Fuller, G N; Lang, F F; Zhang, W

Oncogene. 3/26/2015, Vol. 34 Issue 13, p1619-1628. 10p.

Liuksiala, T; Teittinen, K J; Granberg, K; Heinäniemi, M; Annala, M; Mäki, M; Nykter, M; Lohi, O

Leukemia (08876924). Jan2014, Vol. 28 Issue 1, p233-236. 4p. 1 Chart, 1 Graph.

Rantapero, T; Wahlfors, T; Kahler, A; Hultman, C; Lindberg, J; Tammela, TLJ; Nykter, M; Schleutker, J; Wiklund, F

GENES. 11(3):314-314

Taavitsainen, S; Engedal, N; Cao, S; Handle, F; Erickson, A; Prekovic, S; Wetterskog, D; Tolonen, T; Vuorinen, EM; Kiviaho, A; Nätkin, R; Häkkinen, T; Devlies, W; Henttinen, S; Kaarijärvi, R; Lahnalampi, M; Kaljunen, H; Nowakowska, K; Syvälä, H; Bläuer, M; Cremaschi, P; Claessens, F; Visakorpi, T; Tammela, TLJ; Murtola, T; Granberg, KJ; Lamb, AD; Ketola, K; Mills, IG; Attard, G; Wang, W; Nykter, M; Urbanucci, A

Nat Commun
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Taavitsainen, S, Engedal, N, Cao, S, Handle, F, Erickson, A, Prekovic, S, Wetterskog, D, Tolonen, T, Vuorinen, E M, Kiviaho, A, Nätkin, R, Häkkinen, T, Devlies, W, Henttinen, S, Kaarijärvi, R, Lahnalampi, M, Kaljunen, H, Nowakowska, K, Syvälä, H, Bläuer, M, Cremaschi, P, Claessens, F, Visakorpi, T, Tammela, T L J, Murtola, T, Granberg, K J, Lamb, A D, Ketola, K, Mills, I G, Attard, G, Wang, W, Nykter, M & Urbanucci, A 2021, 'Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse', Nature Communications, vol. 12, no. 1. https://doi.org/10.1038/s41467-021-25624-1
Nature Communications

Chua, C Y; Liu, Y; Granberg, K J; Hu, L; Haapasalo, H; Annala, M J; Cogdell, D E; Verploegen, M; Moore, L M; Fuller, G N; Nykter, M; Cavenee, W K; Zhang, W

Oncogene. Feb 11, 2016 35(6):738-747

Woodcock DJ; Big Data Institute, University of Oxford, Old Road Campus, Headington, Oxford, UK.; Riabchenko E; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Kankainen M; Medical and Clinical Genetics and Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Gundem G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Brewer DS; Norwich Medical School, University of East Anglia, Norwich, UK.; Ellonen P; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, FIN-00290, Helsinki, Finland.; Lepistö M; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, FIN-00290, Helsinki, Finland.; Golubeva YA; Cancer Genomic Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, NCI, FNLCR, Leidos Biomedical Research, Inc, Gaithersburg, MD, USA.; Warner AC; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.; Tolonen T; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.; Jasu J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Isaacs WB; Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Emmert-Buck MR; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Avoneaux Medical Institute, Baltimore, MD, USA.; Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Visakorpi T; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.; Bova GS; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland. steve.bova@tuni.fi.; Wedge DC; Big Data Institute, University of Oxford, Old Road Campus, Headington, Oxford, UK. david.wedge@manchester.ac.uk.; Oxford NIHR Biomedical Research Centre, Oxford, UK. david.wedge@manchester.ac.uk.; Manchester Cancer Research Centre, University of Manchester, Manchester, UK. david.wedge@manchester.ac.uk.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Zhang, K; Myllymäki, S-M; Gao, P; Devarajan, R; Kytölä, V; Nykter, M; Wei, G-H; Manninen, A

Oncogene. October 12, 2017, Vol. 36 Issue 41, p5681.

Gundem, G; Van Loo, P; Kremeyer, B; Alexandrov, LB; Tubio, JMC; Papaemmanuil, E; Brewer, DS; Kallio, HML; Högnäs, G; Annala, M; Kivinummi, K; Goody, V; Latimer, C; O'Meara, S; Dawson, KJ; Isaacs, W; Emmert-Buck, MR; Nykter, M; Foster, C; Kote-Jarai, Z; Easton, D; Whitaker, HC; ICGC Prostate Group; Neal, DE; Cooper, CS; Eeles, RA; Visakorpi, T; Campbell, PJ; McDermott, U; Wedge, DC; Bova, GS

Nature
Gundem, G, Van Loo, P, Kremeyer, B, Alexandrov, L B, Tubio, J M C, Papaemmanuil, E, Brewer, D S, Kallio, H M L, Högnäs, G, Annala, M, Kivinummi, K, Goody, V, Latimer, C, O'Meara, S, Dawson, K J, Isaacs, W, Emmert-Buck, M R, Nykter, M, Foster, C, Kote-Jarai, Z, Easton, D, Whitaker, H C, Neal, D E, Cooper, C S, Eeles, R A, Visakorpi, T, Campbell, P J, McDermott, U, Wedge, D C & Bova, G S 2015, 'The evolutionary history of lethal metastatic prostate cancer', Nature, vol. 520, no. 7547, pp. 353-357. https://doi.org/10.1038/nature14347

Mäntylä, S; Haapasalo, J; Ilvesaro, J; Nordfors, K; Isola, J; Haapasalo, H; Nykter, M; Granberg, K

Publisher: Oxford University Press / USA ISSN: 1522-8517

Hermelo, I; Haapasalo, J; Nordfors, K; Haapasalo, H; Nykter, M; Granberg, K

Publisher: Oxford University Press / USA ISSN: 1522-8517

Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Fu S; Department of Medical Oncology, BC Cancer, Vancouver, Canada; Oncology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.; Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Sipola J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Iqbal N; Medical Oncology, Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Canada.; Ferrario C; Jewish General Hospital, McGill University, Montréal, Quebec, Canada.; Ong M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada.; Wadhwa D; BC Cancer - Kelowna Centre, Kelowna, Canada.; Hotte SJ; Oncology, Juravinski Cancer Centre, Hamilton, Canada.; Lo G; Department of Medical Oncology, R. S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Canada.; Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wood LA; QEII Health Sciences Centre, Halifax, Canada.; Gingerich JR; Department of Medical Oncology and Hematology, Cancer Care Manitoba, Winnipeg, Canada.; North SA; Department of Oncology, University of Alberta, Edmonton, Canada.; Pezaro CJ; Eastern Health Clinical School, Monash University, Australia; Department of Oncology, Eastern Health, Australia.; Ruether JD; Tom Baker Cancer Centre, Calgary, Canada.; Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; Kallio HML; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Khalaf DJ; Department of Medical Oncology, BC Cancer, Vancouver, Canada.; Wong A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Beja K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Schönlau E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada. Electronic address: awwyatt@mail.ubc.ca.; Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, BC Cancer, Vancouver, Canada. Electronic address: kchi@bccancer.bc.ca.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Ampuja M; BioMediTech, University of Tampere, Tampere, Finland. minna.ampuja@uta.fi.; Fimlab Laboratories, Tampere, Finland. minna.ampuja@uta.fi.; Rantapero T; BioMediTech, University of Tampere, Tampere, Finland.; Rodriguez-Martinez A; BioMediTech, University of Tampere, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland.; Palmroth M; BioMediTech, University of Tampere, Tampere, Finland.; Alarmo EL; BioMediTech, University of Tampere, Tampere, Finland.; Nykter M; BioMediTech, University of Tampere, Tampere, Finland.; Kallioniemi A; BioMediTech, University of Tampere, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland.

Publisher: BioMed Central Country of Publication: England NLM ID: 100965258 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2164 (Electronic) Linking ISSN: 14712164 NLM ISO Abbreviation: BMC Genomics Subsets: MEDLINE